Cohort Study to Assess Population Impact of Current and Evolving Chronic Viral Hepatitis Treatment

Funding Opportunity Number: RFA-PS-16-002 Opportunity Category: DiscretionaryFunding Instrument Type: Cooperative AgreementCategory of Funding Activity: HealthCFDA Number: 93.270Eligible Applicants State governmentsCounty governmentsCity or township governmentsSpecial district governmentsIndependent school districtsPublic and State controlled institutions of higher educationNative American tribal governments (Federally recognized)Public housing authorities/Indian housing authoritiesNative American tribal organizations (other than Federally recognized tribal governments)Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher educationNonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher educationPrivate institutions of higher educationFor profit organizations other than small businessesSmall businessesOthers (see text field entitled "Additional Information on Eligibility" for clarification)Agency Name: HHS-CDC-HHSCDCERAClosing Date: Mar 15, 2016Award Ceiling: $500,000Expected Number of Awards: 1Creation Date: Jan 13, 2016Funding Opportunity Description: Chronic hepatitis B and C represent a major health problem for the United States. Approximately 3.2 million Americans are chronically infected with hepatitis C virus and 1.25 million with chronic hepatitis B virus, with an estimated 55,000 hepatitis C virus- related deaths and 2,000-4,000 hepatitis B related deaths e...
Source: Grants.gov - Category: Research Tags: Health Source Type: funding